financetom
Business
financetom
/
Business
/
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $437,325, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $437,325, According to a Recent SEC Filing
Sep 25, 2024 2:19 PM

04:42 PM EDT, 09/25/2024 (MT Newswires) -- Eben Tessari, COO, on September 23, 2024, sold 17,500 shares in Kiniksa Pharmaceuticals International (KNSA) for $437,325. Following the Form 4 filing with the SEC, Tessari has control over a total of 116,975 shares of the company, with 116,975 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000141588924023954/xslF345X05/form4-09252024_080916.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved